{"id":"W3154244221","doi":"10.1080/13696998.2021.1917139","title":"Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Nivolumab; Docetaxel; Population; Clinical trial; Cost effectiveness; Quality-adjusted life year; Internal medicine; Oncology; Randomized controlled trial; Cost–benefit analysis; Demography; Cancer; Environmental health; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107865,0.000119419,0.0005487109,0.00009251044,0.00001566903,0.00001525621,0.00018984,0.0001004718,0.00009904187],"category_scores_gemma":[0.00006052859,0.00009875062,0.00002323706,0.0001022963,0.0000864865,0.0001390166,0.00008168411,0.0003755248,6.293624e-8],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005322066,"about_ca_system_score_gemma":0.0057703,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2906381,"about_ca_topic_score_gemma":0.886995,"domain_scores_codex":[0.9988136,0.00007797503,0.0005180787,0.0002144835,0.0001925621,0.0001833127],"domain_scores_gemma":[0.9990124,0.0002009307,0.0002404916,0.0002348985,0.00006407964,0.0002472252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007148932,0.0003487447,0.9543939,0.001034581,0.0001863396,0.001482366,0.0004667706,0.0003654203,0.001014997,0.000004545125,0.0003463883,0.03320698],"study_design_scores_gemma":[0.03468464,0.0008308233,0.9347342,0.00177102,0.0001819128,0.001009792,0.002206951,0.01957426,0.003453656,0.00001285703,0.001226294,0.0003136033],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959123,0.0027532,0.00005443905,0.0007821049,0.0001923944,0.0002067956,0.00005031919,8.686876e-7,0.00004762107],"genre_scores_gemma":[0.9935021,0.005814588,0.0001818962,0.0003774005,0.00008387722,0.000003805765,0.00001339121,0.00001572132,0.00000715232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5963569,"threshold_uncertainty_score":0.9998661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02007993074301333,"score_gpt":0.2834601182077676,"score_spread":0.2633801874647543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}